A fraction of our early stage NSCLC patients (32/156, 20.5%) received radiation therapy, thus we cannot rule out the possible influence of radiation therapy on the association of ERCC1 rs11615 with survival. This evidence concerns the gene ERCC1 and non-small cell lung carcinoma.